HCW Biologics Inc.
HCWB
$4.99
-$0.27-5.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.29M | -7.96M | -12.05M | -11.40M | -24.75M |
| Total Depreciation and Amortization | 764.70K | 1.04M | 1.57M | 1.52M | 1.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.27M | -3.69M | 470.10K | -651.40K | 1.19M |
| Change in Net Operating Assets | -1.65M | -2.78M | -2.86M | -2.03M | 8.07M |
| Cash from Operations | -11.45M | -13.39M | -12.87M | -12.56M | -14.14M |
| Capital Expenditure | -- | -- | -113.40K | -150.50K | -131.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -113.40K | -150.50K | -131.90K |
| Total Debt Issued | 150.00K | 150.00K | 525.00K | 3.36M | 5.16M |
| Total Debt Repaid | -354.40K | -127.60K | -125.80K | -124.00K | -122.20K |
| Issuance of Common Stock | 8.03M | 8.03M | 11.25M | 9.26M | 3.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.75M | 2.61M | 1.43M | 1.50M | 2.30M |
| Cash from Financing | 11.57M | 10.67M | 13.08M | 13.99M | 11.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.20K | -2.72M | 98.60K | 1.28M | -2.98M |